Sanofi Underplayed Dangers Of Chemo Drug, Suit Says

Law360, New York (March 15, 2016, 8:44 PM EDT) -- Sanofi SA knew that its breast cancer treatment drug Taxotere was more dangerous than its competitors’ products and frequently caused permanent hair loss, but went to great lengths to hide the problem and promote the drug’s alleged superiority, a California woman said in a federal lawsuit filed Friday.

Ami Dodson, who says Sanofi, Aventis Pharma SA and Sanofi-Aventis US LLC engaged in a long-running scheme to drive up Taxotere sales — a plan that caused thousands of patients to be exposed to the drug’s increased toxicity when compared to other similar medications, as well as additional side effects including permanent hair...

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Access to case data within articles (numbers, filings, courts, nature of suit, and more.)
  • Access to attached documents such as briefs, petitions, complaints, decisions, motions, etc.
  • Create custom alerts for specific article and case topics and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

Attached Documents

Related Sections

Case Information

Case Title

Subscribers Only

Case Number

Subscribers Only

Court

Subscribers Only

Nature of Suit

Subscribers Only

Judge

Subscribers Only

Date Filed

Subscribers Only

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Beta
Ask a question!